IBM Complimentary Metal-Oxide Semiconductor (CMOS)

  • Licensing agreement with IBM Research for use of its metal-oxide semi-conductive (CMOS) compatible nanosensors.
  • Gives the potential to provide and objective and real-time assessment of injury or infection at a greater sensitivity and specificity than other traditional point-of-care (POC) tests.

*The NanoDxTM System has not been evaluated by the FDA or other regulatory agencies.

Real-Time, Point-of-Care Diagnostics

(508) 599-2400

144 Turnpike Road Suite 110 Southborough, MA 01772